Home Stock

Stock Research: Niagen Bioscience

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Niagen Bioscience

NAQ:NAGE US1710774076
71
  • Value
    32
  • Growth
    79
  • Safety
    Safety
    48
  • Combined
    67
  • Sentiment
    81
  • 360° View
    360° View
    71
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Niagen Bioscience, Inc. is a global bioscience company focused on research related to nicotinamide adenine dinucleotide (NAD+). The company operates in the dietary supplement and ingredient industries. It supplies ingredients to manufacturers of consumer products and offers NAD+ test kits. In the last fiscal year, the company had a market cap of $876 million, profits of $62 million, and revenue of $100 million, with 104 employees.

more
Strongest Rank Dividend Yield
Weakest Rank Analyst Opinions
Country USA
Industry Life Sciences Tools & Services
Size Small
Website niagenbioscience.com
Index
NASDAQ
Niagen Bioscience stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 19-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
32 10 45 45
Growth
79 93 63 33
Safety
Safety
48 48 75 75
Sentiment
81 72 23 13
360° View
360° View
71 71 14 16
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
97 95 61 83
Opinions Change
50 50 50 50
Pro Holdings
n/a 60 12 13
Market Pulse
42 23 13 12
Sentiment
81 72 23 13
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
32 10 45 45
Growth
79 93 63 33
Safety Safety
48 48 75 75
Combined
67 67 84 84
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
53 45 80 77
Price vs. Earnings (P/E)
57 11 32 44
Price vs. Book (P/B)
19 5 32 26
Dividend Yield
1 1 1 1
Value
32 10 45 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
84 75 76 80
Profit Growth
94 96 85 15
Capital Growth
26 8 13 67
Stock Returns
51 99 45 23
Growth
79 93 63 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
83 77 83 80
Refinancing
57 26 57 55
Liquidity
20 20 37 37
Safety Safety
48 48 75 75

Similar Stocks

Discover high‑ranked alternatives to Niagen Bioscience and broaden your portfolio horizons.

Sandisk

NSQ:SNDK
Country: USA
Industry: Technology Hardware & Peripherals
Size: X-Large
Full Stock Analysis

Aramark

NYQ:ARMK
Country: USA
Industry: Restaurants
Size: X-Large
Full Stock Analysis

Micron

NSQ:MU
Country: USA
Industry: Semiconductors
Size: XX-Large
Full Stock Analysis

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a classic, high-risk growth play: high growth and positive sentiment outweigh low Value Rank (expensive) and risky financing. This is for aggressive growth investors who are comfortable with the high price and risk, believing the growth story justifies the expense.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews